The Peter Attia Drive

Podbit · The Peter Attia Drive

#395 - Brain lipidology: understanding APOE, cholesterol homeostasis, Alzheimer's disease risk, and the effects of lipid-lowering therapies on brain health | Tom Dayspring, M.D.

Explore episode Jun 8, 2026
Health & Fitness
Omega-3s and the Brain: The Journey from Supplement to Neuron

#395 - Brain lipidology: understanding APOE, cholesterol ho… · Jun 8, 2026 Health & Fitness

DHA and EPA reach brain cells via a phospholipid transfer protein shuttle that docks at a specific blood-brain barrier receptor. Both fatty acids matter — EPA is no longer considered secondary. An omega-3 index of 8–9% appears to be the saturation point for systemic cell membranes, though no RCT has proven a specific brain-health threshold.

Where this was said

EPA, DHA, and omega-3 fatty acids in brain health

At 1:23:54 · chapter starts 1:23:15

Tom explains the complete journey of dietary omega-3s from supplement to neuron. After intestinal absorption as free fatty acids or lysophospholipids, EPA and DHA are repackaged into chylomicrons, hydrolyzed in plasma, and then bound by phospholipid transfer protein — a specialized shuttle that carries omega-3-containing phospholipids to the blood-brain barrier, where a specific receptor mediates their entry into the brain. Once inside, they can be incorporated into brain HDL particles or diffuse directly into nearby cells. Tom notes a shift in the field: EPA is no longer considered secondary to DHA; both fatty acids serve important roles in brain cell membrane composition. The evidence hierarchy is mixed: observational data is broadly supportive, and Bill Harris's work suggests an omega-3 index of 8–9% reflects adequate systemic saturation, but no randomized controlled trial has established a brain-specific outcome benefit at any particular index level. Tom is candid that this places omega-3s in 'plausible but unproven' territory for brain health specifically, while the cardiovascular evidence from the REDUCE-IT trial (EPA in high-risk patients with controlled ApoB) is more robust.

Similar podbits

Health & Fitness
AI in Healthcare: Where It Helps and Where It Doesn't

Using AI to Increase Your Intelligence & Enrich Humanity | … · Aug 10, 2026 Health & Fitness

AI nailed Andrew Huberman's vertigo-vs-low-blood-pressure diagnosis because that pattern has been reported millions of times. But every patient's liver is different and data on liver surgeries is scarce worldwide — making solo robot surgery dangerous. The rule is simple: data abundance means AI can help; data scarcity means keep the human in the loop.